ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2094

Examining T Cell Exhaustion in Murine Systemic Lupus Erythematosus

Jeremy Tilstra1, Lyndsay Avery2, Ashley Menk2, Rachael Gordon2, Shuchi Smita3, Lawrence Kane3, Maria Chikina2, Greg Delgoffe3 and Mark Shlomchik4, 1Rheumatology, Univ of Pittsburgh Medical Center, Pittsburgh, PA, 2University of Pittsburgh, Pittsburgh, PA, 3Department of Immunology, University of Pittsburgh, Pittsburgh, PA, 4Immunology, University of Pittsburgh, Pittsburgh, PA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Lupus, lupus nephritis and mouse model, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Systemic Lupus Erythematosus – Animal Models Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: While T cells are important for the pathogenesis of systemic lupus erythematosus (SLE) and lupus nephritis, little is known about how T cells function after infiltrating the kidney in the setting of organ damage. The current paradigm suggests that kidney infiltrating T cells (KITs) are activated effector cells contributing to tissue damage and ultimately organ failure. We aim to examine this hypothesis by directly examining KITs.

Methods: KITs and Splenic CD4+ and CD8+ T cells were isolated from diseased mice in 3 murine models of SLE (MRL/lpr, MRL.TLR9-/- (fas sufficient), and FcγRIIB-/-.Yaa). T cells were evaluated for phenotypic, functional, metabolic, and transcriptional profiles as noted in results.

Results: The majority of CD4+ and CD8+ KITs in all three murine lupus models are not effector cells, as hypothesized, but rather, KITs mimic the “exhausted” phenotype observed in tumor infiltrating T cells. KITs exhibited a significant increase in expression of multiple inhibitory receptors including PD-1, Lag3, and Tim3, and proved highly dysfunctional with reduced cytokine production and proliferative capacity.

Mechanistically this was linked directly to metabolic and specifically mitochondrial dysfunction. This phenotype is driven by the expression of an “exhausted” transcriptional signature.

Conclusion: KITs derived from lupus prone mice are exhibit a phenotypic and transcriptional signature that is analogous to what has been described in the setting of chronic infection and T cell infiltrates in the tumor microenvironment. Our data reveal that the tissue parenchyma has the capability to suppress T cell responses and limit damage to self. These findings may (1) lend insights into autoimmune related adverse events associated with cancer immunotherapy, which targets T cell exhaustion (2) open novel avenues for the treatment of autoimmunity based on selectively exploiting the exhausted phenotype of tissue-infiltrating T cells and (3) inform on pathophysiologic relationships between parenchymal tissues and infiltrating cells in numerous autoimmune disease states.


Disclosure: J. Tilstra, None; L. Avery, None; A. Menk, None; R. Gordon, None; S. Smita, None; L. Kane, None; M. Chikina, None; G. Delgoffe, None; M. Shlomchik, None.

To cite this abstract in AMA style:

Tilstra J, Avery L, Menk A, Gordon R, Smita S, Kane L, Chikina M, Delgoffe G, Shlomchik M. Examining T Cell Exhaustion in Murine Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/examining-t-cell-exhaustion-in-murine-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/examining-t-cell-exhaustion-in-murine-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology